Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD7 (clone TH6Z9Q). We employs the pGEM (CMV-GFP-IL-10-XbaI) vector components and the SynExpress system of the Exons RNA Editing/Negative feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD7
Clone
TH6Z9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
IL-10
Insertion Sites
XbaI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
pGEM
Transformation Accuracy
0.92
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.